UCL researchers have developed an ultrasound helmet that enables deep brain stimulation without surgery, offering hope for ...

The global Neuromodulation Market , valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to ...

ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

The global neuromodulation market size was US$ 2636.4 million in 2021. The global neuromodulation market size is forecast to reach US$ 4,442.50 million by 2030, growing at a compound annual growth ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Presidio Medical, Inc., a clinical-stage medical technology company developing a transformational neuromodulation platform, today announced research ...

This also means neuromodulation devices are relatively shielded from direct pricing pressure and physicians choose based on the merits of the technology, clinical evidence, user experience in ...

Boomerang Medical announced today that it raised $20 million in a Series B financing to support its implantable ...

IRVINE, Calif. - ReShape Lifesciences (NASDAQ:RSLS), a micro-cap company with a market capitalization of $2.69 million specializing in weight loss and metabolic health solutions, has been granted a ...